Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ørestad Kiropraktik & Sundhed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.8% 7.7% 6.3% 10.6% 7.2% 8.7% 14.0% 14.0%   Credit score (0-100)   41 31 36 22 32 28 16 16   Credit rating   BBB BB BBB BB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,658 4,739 4,890 4,142 4,645 5,194 0.0 0.0   EBITDA   898 988 457 211 637 665 0.0 0.0   EBIT   699 746 207 43.0 472 507 0.0 0.0   Pre-tax profit (PTP)   660.1 723.8 189.9 12.4 439.6 479.7 0.0 0.0   Net earnings   514.9 542.5 170.2 9.6 342.9 374.1 0.0 0.0   Pre-tax profit without non-rec. items   660 724 190 12.4 440 480 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   811 668 505 376 368 271 0.0 0.0   Shareholders equity total   661 687 317 101 444 478 48.0 48.0   Interest-bearing liabilities   268 0.0 135 249 23.4 57.9 137 137   Balance sheet total (assets)   1,772 1,770 1,377 1,200 1,151 1,006 185 185   Net Debt   226 -238 107 224 -85.8 23.6 137 137     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,658 4,739 4,890 4,142 4,645 5,194 0.0 0.0   Gross profit growth   28.6% 1.7% 3.2% -15.3% 12.1% 11.8% -100.0% 0.0%   Employees   6 6 6 7 7 8 0 0   Employee growth %   0.0% 0.0% 0.0% 16.7% 0.0% 14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,772 1,770 1,377 1,200 1,151 1,006 185 185   Balance sheet change%   -3.7% -0.1% -22.2% -12.8% -4.1% -12.6% -81.6% 0.0%   Added value   897.9 988.3 456.7 210.7 639.8 664.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -397 -446 -473 -357 -232 -315 -271 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.0% 15.7% 4.2% 1.0% 10.2% 9.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   38.7% 42.1% 13.1% 3.3% 40.2% 47.0% 0.0% 0.0%   ROI %   67.6% 83.7% 31.2% 6.2% 67.8% 87.0% 0.0% 0.0%   ROE %   101.1% 80.5% 33.9% 4.6% 125.9% 81.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   37.3% 38.8% 23.0% 8.4% 38.6% 47.5% 26.0% 26.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   25.1% -24.0% 23.4% 106.2% -13.5% 3.5% 0.0% 0.0%   Gearing %   40.6% 0.0% 42.6% 246.5% 5.3% 12.1% 285.2% 285.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.5% 16.4% 24.6% 16.0% 23.9% 68.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.5 0.7 0.5 0.9 0.9 1.6 0.0 0.0   Current Ratio   0.5 0.7 0.5 0.9 0.9 1.6 0.0 0.0   Cash and cash equivalent   42.9 237.5 28.4 25.2 109.2 34.3 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -556.5 -318.7 -456.8 -77.8 -50.8 197.8 -68.5 -68.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   150 165 76 30 91 83 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   150 165 76 30 91 83 0 0   EBIT / employee   117 124 34 6 67 63 0 0   Net earnings / employee   86 90 28 1 49 47 0 0